These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23156264)

  • 1. [Pathology and current topics on the selected histological types of endometrial carcinoma].
    Kiyokawa T
    Nihon Rinsho; 2012 Jun; 70 Suppl 4():321-6. PubMed ID: 23156264
    [No Abstract]   [Full Text] [Related]  

  • 2. [Histological diagnosis of endometrial cancer in biopsy specimen].
    Kaku T; Watanabe S; Ohishi Y
    Nihon Rinsho; 2012 Jun; 70 Suppl 4():362-6. PubMed ID: 23156271
    [No Abstract]   [Full Text] [Related]  

  • 3. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
    Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
    Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synchronous primary ovarian and endometrial cancer with a fair prognosis in a young woman.
    Yang YH; Chen RJ; Lin MC; Cheng SP; Chang TC
    Taiwan J Obstet Gynecol; 2010 Mar; 49(1):97-100. PubMed ID: 20466303
    [No Abstract]   [Full Text] [Related]  

  • 5. [Histologic diagnosis of endometrial cancer].
    Kaku T; Kawano Y; Hagiwara T
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():309-12. PubMed ID: 15535257
    [No Abstract]   [Full Text] [Related]  

  • 6. Endometrial giant cell carcinoma: a case series and review of the spectrum of endometrial neoplasms containing giant cells.
    Mulligan AM; Plotkin A; Rouzbahman M; Soslow RA; Gilks CB; Clarke BA
    Am J Surg Pathol; 2010 Aug; 34(8):1132-8. PubMed ID: 20588176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial carcinomas: a review emphasizing overlapping and distinctive morphological and immunohistochemical features.
    Bartosch C; Manuel Lopes J; Oliva E
    Adv Anat Pathol; 2011 Nov; 18(6):415-37. PubMed ID: 21993268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A series of ovarian clear cell and endometrioid carcinoma and their association with endometriosis.
    Chew S; Tham KF; Ratnam SS
    Singapore Med J; 1997 Jul; 38(7):289-91. PubMed ID: 9339094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis and the expression of Bcl-2 and Bax in patients with endometrioid, clear cell, and serous carcinomas of the uterine endometrium.
    Kokawa K; Shikone T; Otani T; Nishiyama R; Ishii Y; Yagi S; Yamoto M
    Gynecol Oncol; 2001 May; 81(2):178-83. PubMed ID: 11330946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathology of endometrial hyperplasia and endometrial carcinoma: an update.
    Horn LC; Meinel A; Handzel R; Einenkel J
    Ann Diagn Pathol; 2007 Aug; 11(4):297-311. PubMed ID: 17630117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synchronous clear cell adenocarcinoma of the cervix and endometrioid carcinoma of the endometrium.
    Park ST; Song MJ; Lee CW; Lee AW; Hur SY; Park JS
    Eur J Gynaecol Oncol; 2011; 32(5):573-5. PubMed ID: 22053679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed endometrial carcinomas: morphologic features, pathogenesis, and diagnostic challenges.
    Saez Perrotta MC; Chacon CB; Wernicke A
    Int J Gynecol Cancer; 2021 Feb; 31(2):304-305. PubMed ID: 33526509
    [No Abstract]   [Full Text] [Related]  

  • 13. Endometrial carcinoma tumorigenesis and pharmacotherapy research.
    Shu J; Fang S; Teichman PG; Xing L; Huang H
    Minerva Endocrinol; 2012 Jun; 37(2):117-32. PubMed ID: 22691886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 1999 Sep; 74(3):385-94. PubMed ID: 10479498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas.
    Khalifa MA; Mannel RS; Haraway SD; Walker J; Min KW
    Gynecol Oncol; 1994 Apr; 53(1):84-92. PubMed ID: 7909788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endometrial carcinomas with lymph node involvement: novel histopathologic factors for predicting prognosis.
    Yasunaga M; Yamasaki F; Tokunaga O; Iwasaka T
    Int J Gynecol Pathol; 2003 Oct; 22(4):341-6. PubMed ID: 14501813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling the mystery of clear cell endometrial cancer.
    Bae-Jump V
    Gynecol Oncol; 2020 Jul; 158(1):1-2. PubMed ID: 32580885
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical parameters linked with malignancy in endometrial polyps.
    Gregoriou O; Konidaris S; Vrachnis N; Bakalianou K; Salakos N; Papadias K; Kondi-Pafiti A; Creatsas G
    Climacteric; 2009 Oct; 12(5):454-8. PubMed ID: 19591006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathology of endometrial carcinoma].
    Shiozawa T; Konishi I
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():273-8. PubMed ID: 15535250
    [No Abstract]   [Full Text] [Related]  

  • 20. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.